Aman Jat

Mr. Aman Jat

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
LSLucy Smith
Lucy Smith
LMLysanne Veerle Michels
Lysanne Veerle Michels
AJAman Jat
Aman Jat
JFJames Faulkner
James Faulkner
JKJacob Keast
Jacob Keast
HDHajira Dambha-Miller
Hajira Dambha-Miller
Background: Accurate and consistent measurement of physical activity (PA) is essential for evaluating interventions, informing clinical and public health decision-making, and enabling comparisons across populations. Wearable device–based measures are increasingly used to quantify PA, but the extent to which populations at risk of health inequity, as defined by established equity frameworks, are represented in wearable-based PA studies, and whether measurement protocols are appropriate and comparable across these groups, remains insufficiently characterised. Aim: To synthesise evidence on the use of wearable devices for measuring PA in populations at risk of health inequity, as defined by the PROGRESS-Plus and CORE20PLUS5 frameworks, and to identify methodological features relevant to equity in PA measurement. Methods: A scoping review was conducted in accordance with PRISMA-ScR guidelines. PubMed, Scopus, Web of Science, and grey literature were searched for peer-reviewed randomised controlled trials published between January 2020 and October 2025. Eligible studies quantitatively measured PA using pedometers, accelerometers, or smartwatches in populations at risk of health inequity. Data were extracted on study design, population characteristics, device type and placement, monitoring protocols, and equity-related considerations. Results: Of 1,027 records screened, 13 studies met inclusion criteria. Wrist-worn pedometers and hip-worn accelerometers were most common. Adaptations were minimal and largely limited to language translation. Several high-risk equity groups according to the frameworks used including LGBTQ+, people experiencing homelessness, those with learning difficulties, substance misuse, and justice system involvement were absent. Conclusions: This review demonstrates that wearable-based PA measurement has been applied to only a narrow subset of populations at risk of health inequity, with notable gaps across several key PROGRESS-Plus and CORE20PLUS5 groups. Methodological adaptations to support equitable measurement were uncommon and largely superficial, raising concerns about the appropriateness, acceptability, and comparability of PA data generated in these contexts. Addressing these methodological and reporting deficiencies is essential to strengthen the evidence base and prevent the widening of inequities in PA surveillance and intervention evaluation.

6 October 2026 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
AJAman Jat
Aman Jat
SZSalwa S. Zghebi
Salwa S. Zghebi
Jana SuklanJana Suklan
Jana Suklan
LSLucy Smith
Lucy Smith
HDHajira Dambha-Miller
Hajira Dambha-Miller
Background: Artificial intelligence-enabled tools are increasingly used to support mental health diagnosis, triage and clinical decision-making. However, limited evidence exists on whether these tools incorporate equity-relevant population characteristics, particularly among people living with multiple long-term conditions (MLTC), who often experience complex health needs and structural inequalities. Methods: We conducted a cross-sectional analysis using linked Clinical Practice Research Datalink Gold and Aurum primary care data for 7,186,890 adults aged ≥ 18 years with MLTC in England between 1987 and 2020. Five artificial intelligence-based mental health diagnostic or triage tools identified through a scoping review were operationalised using routinely collected primary care variables. Many symptom-level psychiatric inputs central to the original models could not be captured in routine primary care data and were excluded. Reported tool inputs were mapped to sociodemographic, clinical and social-care factors, including deprivation, ethnicity, age, sex, disability, place of residence and social care involvement, informed by the CORE20PLUS5 and PROGRESS-PLUS frameworks. We calculated an Equity-Variable Coverage Index to quantify the proportion of equity-relevant variables each tool includes as inputs, a measure of input coverage rather than demonstrated fairness. To illustrate the empirical importance of these characteristics, we fitted multivariable logistic regression models for hospital admission, a proxy outcome influenced by system-level and clinical factors, with leave-one-out removal of each equity-related variable. Results: Equity domain coverage varied substantially across tools, ranging from 13.0% to 56.5%. Clinical characteristics were more consistently represented than sociodemographic or social-care factors. Drug and alcohol misuse was included in all five tools, whereas age, ethnicity, deprivation, disability status and social care involvement were inconsistently incorporated. Removing ethnicity and age produced the largest reductions in model explanatory performance, followed by outpatient attendance, Accident and Emergency attendance, and drug and alcohol misuse, indicating that several under-represented equity-relevant variables were associated with hospital admission among adults with MLTC. Conclusions: Current artificial intelligence-enabled mental health tools show substantial and variable gaps in their coverage of equity-relevant population characteristics available in routine UK primary care data. Embedding equity considerations into tool design and routinely evaluating model inputs and performance using population-scale data will support fair and responsible deployment of mental health artificial intelligence.

10 August 2026 in BMC Medicine
Verified
Journal Article
Open access
PDF file
AJAman Jat
Aman Jat
BBBenjamin D Barton
Benjamin D Barton
RMRohini Mathur
Rohini Mathur
BSBeth Stuart
Beth Stuart
HHHilda Hounkpatin
Hilda Hounkpatin
HDHajira Dambha-Miller
Hajira Dambha-Miller
Background: Multiple long-term conditions (MLTC) are increasingly prevalent among UK adults, yet the extent to which remission of long-term conditions is recorded in routine primary care remains poorly understood. Accurate documentation of remission has implications for clinical management, disease trajectories, and the use of electronic health records in research. Examining remission in the context of MLTC is important because remission in one condition may alter overall disease burden and treatment needs in people living with several coexisting conditions. We aimed to describe the frequency and variation of recorded remission across multiple long-term conditions among adults. Methods: We conducted a retrospective cohort study using linked primary care, hospital, and CPRD Aurum data. Adults aged ≥ 18 with MLTC (≥ 2 long-term conditions) between Jan 1, 1987, and Dec 31, 2020, were included. Remission was defined using condition-specific criteria based on remission or resolution codes, relevant clinical measurements meeting predefined thresholds, treatment patterns, and condition-specific clinical events recorded in electronic health records. We examined remission for 10 conditions with operationalizable definitions. Analyses were descriptive, summarising remission frequencies and sociodemographic patterns. Results: Among 4,745,099 adults followed for a median of 8 years, 900,609 (19%) had recorded remission of at least one condition. Remission varied substantially by condition, with the highest rates observed for anaemia (63.0%), asthma (44.71%), and diabetes (15.51%), calculated among people with an ever-recorded diagnosis of each condition. Those with remission were slightly younger and more often male; Asian and Black ethnic groups were under-represented, while deprivation patterns were broadly similar. Conclusions: Recorded remission in MLTC is highly heterogeneous and often rare. Variation between conditions and low rates of sustained remission likely reflect coding practices and clinical recording behaviours. Standardised remission definitions and consistent Systematised Nomenclature of Medicine (SNOMED) coding could improve data quality and support more reliable research on remission and disease trajectories.

31 October 2025 in medRxiv
Verified
Preprint
Open access
PDF file
TITassella Isaac
Tassella Isaac
AJAman Jat
Aman Jat
LSLucy Smith
Lucy Smith
YYYousef Yousef
Yousef Yousef
RVRishika Vashishtha
Rishika Vashishtha
HDHajira Dambha-Miller
Hajira Dambha-Miller
Background: Multimorbidity (the coexistence of two or more long-term conditions) is increasingly prevalent, particularly among older adults, and is a major driver of healthcare expenditure. However, healthcare costs reflect only part of the overall burden. Many people with multimorbidity also depend on social care services for personal support, mobility assistance, and social engagement to preserve independence and quality of life. Despite its significance for individuals, families, and the health system, the economic impact of social care needs related to multimorbidity has not been quantified at a population level in England. Methods: We conducted a retrospective, population-based cohort study of adults (≥18 years) with multimorbidity using data from the CPRD Gold and Aurum datasets covering 1987–2020. Social care needs were identified through coded indicators across three domains (personal care, mobility, and social interaction) and valued using 2019–2020 national unit costs from the Personal Social Services Research Unit (PSSRU). Adjusted per-capita costs were estimated via direct standardisation by age, sex, ethnicity, and socioeconomic deprivation. Results: The cohort comprised 5,771,603 adults with multimorbidity (mean age 56.5 years; 55.1% female). Among them, 800,309 individuals (13.9%) had at least one recorded social care need. Personal care accounted for the majority of costs (£3.66 billion; 84.3% of total), affecting 7.3% of the cohort with a mean annual expenditure of £8,736 per user. Mobility needs represented £336.8 million (7.8%) and social interaction needs £346 million (8.0%), with mean annual costs of £1,426 and £709 per user, respectively. Individuals with multiple needs (6.3% of the cohort) incurred mean annual costs of £9,076. Social care needs and costs were higher among older adults, women, and those living in more deprived areas. Conclusion: This study provides the first population-level estimate of social care costs associated with multimorbidity in England. Social care represents an important yet often overlooked component of the broader economic burden of multimorbidity. Costs are predominantly concentrated in personal care and vary systematically by demographic and socioeconomic factors, underscoring potential inequities in service access or provision. Integrating social care within multimorbidity strategies is essential to address the full scale of its societal impact.

14 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
AJAman Jat
Aman Jat
BBBenjamin Barton
Benjamin Barton
RMRohini Mathur
Rohini Mathur
TITassella Isaac
Tassella Isaac
BSBeth Stuart
Beth Stuart
HDHajira Dambha-Miller
Hajira Dambha-Miller
Background Multimorbidity is increasingly prevalent among UK adults, yet the extent to which remission of long-term conditions is recorded in routine primary care remains poorly understood. Accurate documentation of remission has implications for clinical management, disease trajectories, and interpretation of electronic health records for research. We aimed to describe the frequency and variation of recorded remission across multiple long-term conditions among adults with multimorbidity. Methods We conducted a retrospective cohort study using linked primary care, hospital, and CPRD Aurum data. Adults aged ≥18 with multimorbidity (≥2 long-term conditions) between Jan 1, 1987, and Dec 31, 2020, were included. Remission was defined using condition-specific criteria based on diagnostic or resolution codes, clinical measurements, treatment patterns, and relevant clinical events. We examined remission for 11 conditions with operationalizable definitions. Analyses were descriptive, summarising remission frequencies and sociodemographic patterns. Findings Among 4,745,099 adults followed for a median of 8 years, 900,609 (18.1%) had recorded remission of at least one condition. Remission varied substantially by condition and was highest for endometriosis (90.36%), anaemia (63.0%), asthma (44.71%), and diabetes (15.51%), calculated among individuals with an ever-recorded diagnosis of each condition. Individuals with remission were slightly younger and more often male; Asian and Black ethnic groups were under-represented, while deprivation patterns were broadly similar. Interpretation Recorded remission in multimorbidity is highly heterogeneous and often rare. Variation between conditions and low rates of sustained remission likely reflect coding practices and clinical recording behaviours. Standardised remission definitions and consistent Systematized Nomenclature of Medicine (SNOMED) coding could improve data quality and support more reliable research on remission and disease trajectories.